O3 Biotech Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$1.55M
- Investors
-
3
O3 Biotech General Information
Description
Operator of a biotech company intended to create a good livestock environment and better nutrition through cleaner air, agri-feed, and water supplies. The company specializes in the purification of feed, air, and water utilizing ozone treatments and reducing reliance on chemicals, and a lower carbon footprint, as well as helping to improve natural ozone levels, enabling clients to save costs and get sustainable products.
Contact Information
Website
www.o3biotech.comCorporate Office
- Dorset Innovation Park
- Winfrith Newburgh
- Dorchester DT2 8GB
- England, United Kingdom
Corporate Office
- Dorset Innovation Park
- Winfrith Newburgh
- Dorchester DT2 8GB
- England, United Kingdom
O3 Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 01-Apr-2022 | $1.55M | Completed | Generating Revenue | ||
| 2. Grant | 01-May-2020 | Completed | Startup | |||
| 1. Early Stage VC | Completed | Startup |
O3 Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
O3 Biotech Patents
O3 Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4794738-A1 | Treatment system and method for sanitizing a granular material | Pending | 16-Oct-2023 | ||
| WO-2025083526-A1 | Treatment system and method for sanitizing a granular material | Inactive | 16-Oct-2023 | ||
| WO-2023017496-A1 | An ozone treatment system | Inactive | 13-Aug-2021 | ||
| GB-202111671-D0 | Oxidising system | Active | 13-Aug-2021 | ||
| GB-2615288-A | Oxidising system | Active | 13-Aug-2021 | A23B9/18 |
O3 Biotech Signals
O3 Biotech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Infinium Partners | Venture Capital | Minority | ||
| UK Research and Innovation | Government | |||
| Led By Reason | Venture Capital | Minority |
O3 Biotech FAQs
-
When was O3 Biotech founded?
O3 Biotech was founded in 2016.
-
Where is O3 Biotech headquartered?
O3 Biotech is headquartered in Dorchester, United Kingdom.
-
What is the size of O3 Biotech?
O3 Biotech has 2 total employees.
-
What industry is O3 Biotech in?
O3 Biotech’s primary industry is Other Agriculture.
-
Is O3 Biotech a private or public company?
O3 Biotech is a Private company.
-
What is the current valuation of O3 Biotech?
The current valuation of O3 Biotech is .
-
What is O3 Biotech’s current revenue?
The current revenue for O3 Biotech is .
-
How much funding has O3 Biotech raised over time?
O3 Biotech has raised $1.55M.
-
Who are O3 Biotech’s investors?
Infinium Partners, UK Research and Innovation, and Led By Reason have invested in O3 Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process